Home / Medical Devices / Coronary Stents Market By Product (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Scaffolds) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Coronary Stents Market By Product (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Scaffolds) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Aug 2018 | Report Code: 59273-08-18

Industry Outlook

The coronary stents market is set to reach US$ 11,622.5 Mn by 2026 from US$ 6,216.7 Mn in 2017 promising impressive growth at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2018 to 2026. According to the research citing’s of World Health Organization (WHO) 2016 report, cardiovascular disease is responsible for the death of 17.7 million people throughout the globe. 75% of these deaths are occurring in the low and middle income countries. The major factors that increase the risk of cardiovascular disease are tobacco smoking, physical inactivity and unhealthy diet. There has been a technological revolution in the development of stents in the last 2 decades. Bare metal stents are being completely overshadowed by drug eluting stents and bioresorbable vascular scaffolds.

Food and Drug Administration (FDA) has approved bioresorbable scaffolds such as Magmaris (Biotronik) and MAGNITUDE® (Amaranth Medical, Inc.) for treating the coronary artery diseases in young population. Effective treatment guidelines have been postulated by World Health Organization (WHO) wherein people at risk for cardiovascular disease must have five servings of vegetable and fruit every day and limit salt intake to prevent heart attack and strokes. Rising public health awareness and domicile of key players drive the market growth in developed nations such as North America and Europe. Increasing medical tourism and affordable reimbursement scenario promote the market growth in Asia Pacific.

Market Synopsis

Coronary Stents Market

Get a sample copy for more information

Excellent patient compliance and minimal risk of restenosis to spur the growth of drug eluting stents

In the current scenario the drug eluting stents are dominating the products segment for coronary stents market. The key drivers that spurt the market growth are excellent patient compliance and minimal risk for restenosis. The other inherent features associated with drug eluting stents are thinner struts, innovative stent structures, biodegradable polymer coating, durable metal alloys and encapsulation of more effective antiproliferative agent on the stent surface. Bare metal stents have been almost replaced in the last decade due to the risk associated with restenosis in patients suffering with diabetic cardiomyopathy. It is still the stent of first choice in developing nations on account of its low cost. Bioresorbable vascular scaffolds will register impressive growth during the forecast period 2018 to 2026 on account of factors such as elimination of stent-in-stent procedures, enhanced vessel healing and reduction in the need for dual antiplatelet therapy.

Coronary Stents Market

Get a sample copy for more information

Rising prevalence of obesity and increasing demand for minimally invasive surgical procedures drives the market growth in North America

North America accounts for 40% share in coronary stents market making it the unanimous leader in the regional segment. The factors that propel the coronary stents market growth in North America are rising prevalence of obesity, unhealthy lifestyle and smoking. The increasing demand for minimally invasive surgical procedure has a positive impact on the market growth in North America. As per the latest research citing’s of European Society of Cardiology (ESC) 2016, cardiovascular disease is the leading cause of mortality in the European Union. Every year 6 million cases are reported for suffering with coronary artery disease. Effective treatment guidelines and well developed healthcare infrastructure drives the coronary stents market in Europe. Proactive initiatives taken by government healthcare agencies and supportive regulatory environment are responsible for the coronary stents market growth in Asia Pacific.

Coronary Stents Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Quantitative analysis is performed for the report coronary stents market on the basis of the existing market trends. The market is segmented as by products and geography.

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Drug Eluting Stents
 • Bare Metal Stents
 • Bioresorbable Vascular Scaffolds

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S. and Canada)
 • Europe (U.K., Germany, and Rest of Europe)
 • Asia Pacific (Japan, China, and Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of Middle East and Africa)

Quantitative and qualitative analysis are used as market assessment tools to understand the market trends prevailing in coronary stents market. Market estimation and compound annual growth rate is provided for the forecast period 2018 to 2026. Marketing strategies related to collaborations, merger & acquisitions are studied to determine company’s inorganic and organic growth policies. Diverse range of coronary stents are showcased in the product portfolio section. The major players engaged in the manufacturing of coronary stents are Amaranth Medical, Inc., Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Inc., B. Braun Melsungen AG, C.R. Bard, Inc., Biotronik SE & Co. KG, Medtronic Plc, Terumo Corporation and Microport Scientific Corporation.

Key questions answered in this report

  • What will be the market estimation and compound annual growth rate for the forecast period 2018 to 2026?
  • Who are the major players dominating the coronary stents market?
  • What are the quantitative and qualitative market analysis that determine the existing trend in coronary stents market?
  • What are the marketing strategies related to collaboration, merger and acquisition between major players in coronary stents market?
  • What is the disease etiology of cardiovascular diseases and how coronary stents are used as a treatment option?
  • Which is the largest and fastest growing coronary stents by product?
  • Which is the largest and fastest growing regional market for coronary stents?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global CS Market Portraiture
2.2. Global CS Market, by Product, 2017 (US$ Mn)
2.3. Global CS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Coronary Stents (CS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CS Market, by Key Players, 2017

Chapter 4. Global Coronary Stents (CS) Market, by Product
4.1. Overview
4.2. Drug Eluting Stent
4.3. Bare Metal Stent
4.4. Bioresorbable Vascular Scaffolds

Chapter 5. Global Coronary Stents (CS) Market, by Geography
5.1. Overview
5.2. North America CS Market Analysis, 2016 – 2026
5.2.1. North America CS Market, by Product, 2016 – 2026 (US$ Mn)
5.2.2. North America CS Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe CS Market Analysis, 2016 – 2026
5.3.1. Europe CS Market, by Product, 2016 – 2026 (US$ Mn)
5.3.2. Europe CS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific CS Market Analysis, 2016 – 2026
5.4.1. Asia Pacific CS Market, by Product, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific CS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America CS Market Analysis, 2016 – 2026
5.5.1. Latin America CS Market, by Product, 2016 – 2026 (US$ Mn)
5.5.2. Latin America CS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa CS Market Analysis, 2016 – 2026
5.6.1. MEA CS Market, by Product, 2016 – 2026 (US$ Mn)
5.6.2. MEA CS Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Amaranth Medical, Inc.
6.3. Biotronik SE & Co. KG
6.4. B.Braun Melsungen AG
6.5. Boston Scientific Corporation
6.6. Cook Medical, Inc.
6.7. C.R. Bard, Inc.
6.8. Johnson & Johnson
6.9. Medtronic, Plc
6.10. Microport Scientific Corporation
6.11. Terumo Corporation

* CS - Coronary Stents

FIG. 1 Coronary Stents (CS) Market: Research Methodology
FIG. 2 CS Market Segmentation
FIG. 3 Global CS Market, by Product, 2017 (US$ Mn)
FIG. 4 Global CS Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global CS Market, by Key Players, 2017
FIG. 7 Global Drug Eluting Stents Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Bare Metal Stents Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Bioresorbable Vascular Scaffolds Market, 2016 – 2026 (US$ Mn)
FIG. 10 U.S. CS Market, 2016 – 2026 (US$ Mn)
FIG. 11 Canada CS Market, 2016 – 2026 (US$ Mn)
FIG. 12 U.K. CS Market, 2016 – 2026 (US$ Mn)
FIG. 13 Germany CS Market, 2016 – 2026 (US$ Mn)
FIG. 14 Rest of Europe CS Market, 2016 – 2026 (US$ Mn)
FIG. 15 China CS Market, 2016 – 2026 (US$ Mn)
FIG. 16 Japan CS Market, 2016 – 2026 (US$ Mn)
FIG. 17 Rest of Asia Pacific CS Market, 2016 – 2026 (US$ Mn)
FIG. 18 Brazil CS Market, 2016 – 2026 (US$ Mn)
FIG. 19 Mexico CS Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Latin America CS Market, 2016 – 2026 (US$ Mn)
FIG. 21 GCC CS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Middle East and Africa CS Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Coronary Stents (CS) Market Portraiture
TABLE 2 Global CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global CS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 North America CS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 Europe CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 7 Europe CS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 Asia Pacific CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific CS Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America CS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Middle East and Africa CS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa CS Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 Amaranth Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Biotronik SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 B.Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 C.R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Medtronic, Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Microport Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients